IRIS
GIACOMELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.663
NA - Nord America 12.534
EU - Europa 4.567
SA - Sud America 1.919
AF - Africa 282
Continente sconosciuto - Info sul continente non disponibili 172
OC - Oceania 55
AN - Antartide 1
Totale 35.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.949
SG - Singapore 8.507
CN - Cina 2.736
HK - Hong Kong 2.230
IT - Italia 2.120
BR - Brasile 1.395
VN - Vietnam 777
GB - Regno Unito 698
FR - Francia 565
BD - Bangladesh 416
CA - Canada 279
DE - Germania 271
IN - India 227
RU - Federazione Russa 212
AR - Argentina 186
NL - Olanda 137
ID - Indonesia 134
IL - Israele 113
MX - Messico 104
EC - Ecuador 102
CO - Colombia 95
UA - Ucraina 93
TR - Turchia 83
ZA - Sudafrica 80
JP - Giappone 74
ES - Italia 70
IQ - Iraq 58
SC - Seychelles 58
PL - Polonia 51
AU - Australia 50
CL - Cile 40
FI - Finlandia 38
PY - Paraguay 36
SA - Arabia Saudita 36
SE - Svezia 34
CZ - Repubblica Ceca 33
CR - Costa Rica 32
MA - Marocco 32
AT - Austria 31
JM - Giamaica 31
PK - Pakistan 31
PE - Perù 26
PH - Filippine 26
VE - Venezuela 26
GT - Guatemala 25
HN - Honduras 24
RO - Romania 24
EG - Egitto 23
MD - Moldavia 23
PT - Portogallo 22
TN - Tunisia 22
SV - El Salvador 20
UZ - Uzbekistan 20
KZ - Kazakistan 16
MY - Malesia 16
NP - Nepal 15
JO - Giordania 14
TT - Trinidad e Tobago 14
KE - Kenya 13
LT - Lituania 13
NI - Nicaragua 13
TH - Thailandia 13
IE - Irlanda 12
IR - Iran 12
OM - Oman 12
AE - Emirati Arabi Uniti 11
DK - Danimarca 11
PR - Porto Rico 11
AL - Albania 10
BG - Bulgaria 10
EE - Estonia 10
LB - Libano 10
AZ - Azerbaigian 9
DZ - Algeria 9
GP - Guadalupe 9
BE - Belgio 8
CH - Svizzera 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
KR - Corea 8
GR - Grecia 7
SK - Slovacchia (Repubblica Slovacca) 7
UY - Uruguay 7
AD - Andorra 6
CW - ???statistics.table.value.countryCode.CW??? 6
KW - Kuwait 6
RS - Serbia 6
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
BO - Bolivia 5
CG - Congo 5
GH - Ghana 5
HU - Ungheria 5
LU - Lussemburgo 5
LV - Lettonia 5
QA - Qatar 5
SN - Senegal 5
IS - Islanda 4
PA - Panama 4
PS - Palestinian Territory 4
Totale 34.935
Salva come PNG Salva come JPEG
Città #
Ashburn 3.081
San Jose 2.945
Hong Kong 2.200
Singapore 1.721
Rome 1.312
Hefei 1.104
Council Bluffs 789
Boardman 620
Columbus 577
London 527
Beijing 491
Lauterbourg 473
Dallas 365
Shanghai 361
Ho Chi Minh City 298
Santa Clara 194
New York 182
Hanoi 153
Los Angeles 148
Phoenix 140
São Paulo 115
Pune 97
San Francisco 96
Amsterdam 83
Toronto 80
Naples 67
Washington 64
Milan 61
Munich 61
Seattle 57
Tokyo 53
Mexico City 48
Montreal 47
Brooklyn 44
Atlanta 43
Chicago 41
Brasília 40
Denver 39
Haiphong 37
Warsaw 37
Buffalo 36
Frankfurt am Main 36
Las Vegas 36
Rio de Janeiro 36
Da Nang 34
Guayaquil 33
Baghdad 31
Bari 31
North Bergen 30
Ankara 29
Quito 29
Johannesburg 28
Turin 27
San José 25
Stockholm 24
Turku 23
Biên Hòa 22
Guangzhou 22
Porto Alegre 22
Bogotá 21
Boston 21
Curitiba 21
Florence 21
Nuremberg 21
Buenos Aires 20
Chennai 20
Medellín 20
Thái Bình 20
West Jordan 20
Brno 19
Bologna 18
Campinas 18
Cape Town 18
Charlotte 18
Guatemala City 18
Hải Dương 18
Jinan 18
Manchester 18
Philadelphia 18
Belo Horizonte 17
Kingston 17
Palermo 17
San Salvador 17
Sydney 17
Vienna 17
Guarulhos 16
Hangzhou 16
Lima 16
Tashkent 16
The Dalles 16
Jakarta 15
Riyadh 15
Changsha 14
Manaus 14
San Antonio 14
Can Tho 13
Dhaka 13
Helsinki 13
Madrid 13
Managua 13
Totale 20.150
Salva come PNG Salva come JPEG
Nome #
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 277
------- 249
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 244
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 241
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 235
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 229
A comprehensive review on adult onset Still's disease 228
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 219
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 217
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 214
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 214
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 211
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 204
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 200
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 200
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 199
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 199
Adult-onset Still's disease with elderly onset: results from a multicentre study 189
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 185
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 183
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 181
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 179
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 179
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 179
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 173
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 154
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 138
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry 135
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 132
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 129
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod 129
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 128
Recent advances and evolving concepts in Still's disease 127
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 127
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease 126
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 125
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 125
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 124
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 123
Cytokine storm syndrome in severe COVID-19 121
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 120
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 119
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 116
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 115
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 114
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 113
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 112
How the different systemic organ involvements are overlapped in patients with primary Sjogren syndrome: analysis using a mathematical model 111
Development and implementation of the AIDA International Registry for patients with Behçet's disease 110
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 110
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 108
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 108
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 105
Polyclonal B lymphocyte activation in progressive systemic sclerosis. 105
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 105
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 104
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 104
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 103
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 103
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 101
The economic burden of fibromyalgia: A systematic literature review 100
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 99
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 99
The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review 99
Cardiovascular disease in primary sjögren’s syndrome 98
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 95
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 93
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 93
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 93
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort 91
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 89
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 88
Vascular complications of scleroderma 87
Hyperuricemia in Psoriatic Arthritis: Epidemiology, Pathophysiology, and Clinical Implications 86
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 85
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome 85
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 84
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 83
Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis 83
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 83
The Vessels Contribute to Fibrosis in Systemic Sclerosis 83
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 82
Primary versus systemic-sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors 82
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 81
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 81
Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis 81
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 81
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 80
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. 80
Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications 79
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 79
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 79
Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome 78
Systemic Sjogren presenting without sicca syndrome: characterization of 240 patients according to the new 2017 ACR/EULAR Classification Criteria 78
SCLERODERMA FIBROBLASTS SUPPRESS ANGIOGENESIS VIA TGF-beta/CAVEOLIN-DEPENDENT SECRETION OF PIGMENTED EPITHELIUM DERIVED FACTOR: TGF-beta RECEPTOR INHIBITORS AS A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF SCLERODERMA 78
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 78
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 77
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 77
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 77
Maladaptive Autophagy in the Pathogenesis of Autoimmune Epithelitis in Sjögren's Syndrome 77
Totale 12.758
Salva come PNG Salva come JPEG
Categoria #
all - tutte 270.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 270.265
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022610 0 0 0 0 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/202510.867 230 179 617 113 109 364 242 64 1.422 1.088 3.012 3.427
2025/202616.151 1.556 496 1.216 2.243 456 944 4.069 1.311 1.231 1.258 801 570
2026/20275.423 183 1.433 1.246 1.763 798 0 0 0 0 0 0 0
Totale 35.193